- Global Pharma News & Resources

Clasado steps up GPA engagement with executive board and committee appointments

Clasado steps up GPA engagement with executive board and committee appointments

Clasado Biosciences ('Clasado'), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has announced that it will be stepping up its membership of the Global Prebiotic Association (‘GPA’) to executive board level. 

Senior leadership team members at Clasado have been appointed to join key GPA committees. While CEO Per Rehné joins the association board, Dr Frederic Narbel, VP of Sales B2B, joins the GPA Communications committee as Vice-Chair and R&D Director, Dr Lucien Harthoorn, has been appointed to the Science & Technical committee.

The Global Prebiotic Association organisation aims to raise awareness of prebiotics around the world to consumers, brands and healthcare professionals. As part of the executive board, Clasado will play a more instrumental role within the organisation, whose activities include events, workshops and developing resources to promote the benefits of prebiotics and the science behind the category.

While Clasado has been part of the association for several years, its Chief Executive Officer, Per Rehné, feels that the time is right to further cement Clasado’s commitment to building knowledge and awareness around gut health in the broader industry. 

He commented: “By amplifying our membership of the GPA, we intend to not just further accelerate our efforts in conveying the important messages surrounding gut health, but to contribute to a deeper scientific understanding of the gut microbiome. In terms of our understanding of the significant role gut bacteria plays in our physical wellbeing, we are only scratching the surface of its potential – it's an exciting time for the prebiotic category”.

“By partnering with GPA at board level and stepping up our committee involvement, we will accelerate prebiotic awareness and help to make better gut health more accessible around the globe.” 

Clasado is the developer and manufacturer of Bimuno®, an award-winning prebiotic ingredient that is the most widely studied of its kind, supported by over 100 scientific publications and more than 20 clinical trials. 

As part of its efforts to boost global knowledge of prebiotics, Clasado has supported the Global Prebiotics Week, an awareness event hosted by the GPA. The event held in November marked the second Global Prebiotics Week after its inauguration in 2020.

Commenting on the committee appointments, Dr Narbel added: “Dr Harthoorn and I are delighted to join the GPA Technical & Science and Communications committees respectively. Our team believes in leading from the front and being a real catalyst for change. As the prebiotic category continues its remarkable upward trajectory, we are proud to share our expertise and perspective and support the long-term success of industry.”

To find out more about Clasado Biosciences, please visit

Editor Details

Last Updated: 15-Dec-2021